Plans to list krill fishing company Superba -- formerly Aker BioMarine -- on the United States stock exchange have been postponed, according to reports in Dagens Næringsliv.
Norwegian magnate Kjell Inge Rokke, the main shareholder of Aker, which owns Aker Biomarine, was set to launch krill pills on the US stock exchange, but that idea has now been put on hold.
Aker, Kjell Inge Rokke’s investment firm, has worked for some time with a view to listing the krill company Superba in the United States, which is actually the stock exchange flop Aker Biomarine under a new name.
However
